Anne Marie Comeau to Predictive Value of Tests
This is a "connection" page, showing publications Anne Marie Comeau has written about Predictive Value of Tests.
Connection Strength
0.199
-
Hale JE, Parad RB, Dorkin HL, Gerstle R, Lapey A, O'Sullivan BP, Spencer T, Yee W, Comeau AM. Cystic fibrosis newborn screening: using experience to optimize the screening algorithm. J Inherit Metab Dis. 2010 Oct; 33(Suppl 2):S255-61.
Score: 0.067
-
Comeau AM, Hale JE, Pai SY, Bonilla FA, Notarangelo LD, Pasternack MS, Meissner HC, Cooper ER, DeMaria A, Sahai I, Eaton RB. Guidelines for implementation of population-based newborn screening for severe combined immunodeficiency. J Inherit Metab Dis. 2010 Oct; 33(Suppl 2):S273-81.
Score: 0.067
-
Pass K, Green NS, Lorey F, Sherwin J, Comeau AM. Pilot programs in newborn screening. Ment Retard Dev Disabil Res Rev. 2006; 12(4):293-300.
Score: 0.049
-
Zytkovicz TH, Fitzgerald EF, Marsden D, Larson CA, Shih VE, Johnson DM, Strauss AW, Comeau AM, Eaton RB, Grady GF. Tandem mass spectrometric analysis for amino, organic, and fatty acid disorders in newborn dried blood spots: a two-year summary from the New England Newborn Screening Program. Clin Chem. 2001 Nov; 47(11):1945-55.
Score: 0.009
-
McIntosh K, Comeau AM, Wara D, Diaz C, Landesman S, Pitt J, Rich K, Lew J, Moye J, Kalish LA. The utility of IgA antibody to human immunodeficiency virus type 1 in early diagnosis of vertically transmitted infection. National Institute of Allergy and Infectious Diseases and National Institute of Child Health and Human Development Women and Infants Transmission Study Group. Arch Pediatr Adolesc Med. 1996 Jun; 150(6):598-602.
Score: 0.006